These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1242350)

  • 1. [Systematic collection of drug side effects].
    May B
    Arzneimittelforschung; 1975 Jul; 25(7a):1215-20. PubMed ID: 1242350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient recognition of adverse drug reactions.
    Simon K
    Acta Med Hung; 1987; 44(1):65-9. PubMed ID: 3671020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The planning of a national drug monitoring system.
    Esch AF
    World Health Organ Tech Rep Ser; 1972; 498():44-7. PubMed ID: 4625551
    [No Abstract]   [Full Text] [Related]  

  • 4. [The system of drug side effects monitoring in the cardiological wards of the University Hospital No. 1 in Poznań. 6-year observation].
    Jabłecka A; Jankowski J; Andrys I
    Wiad Lek; 2000; 53(5-6):277-82. PubMed ID: 10983382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Swedish drug monitoring system.
    Westerholm B
    World Health Organ Tech Rep Ser; 1972; 498():26-36. PubMed ID: 4625549
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence, significance and epidemiology of drug side effects].
    Hoigné R; Maurer P; Wymann R; Fritschy D; Maibach R; Hess T; Müller U; Galeazzi R
    Ther Umsch; 1987 Dec; 44(12):929-37. PubMed ID: 3327187
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to drugs. WHO research centre.
    Venulet J
    Int J Clin Pharmacol; 1973 Apr; 7(2):253-64. PubMed ID: 4731291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Voluntary reporting of adverse reactions to drugs].
    Laporte JR; Porta M; Capellà D; Frati ME
    Med Clin (Barc); 1982 Oct; 79(6):287-91. PubMed ID: 6755090
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of computers in international drug monitoring.
    WHO Chron; 1973 Nov; 27(11):476-80. PubMed ID: 4756664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International drug monitoring: the role of national centres. Report of a WHO meeting.
    World Health Organ Tech Rep Ser; 1972; 498():1-25. PubMed ID: 4625548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse drug reactions: a pilot study on patient reporting through patient associations].
    Nasrallah-Irles D; Castot A; Thomas L; Babai S; Delorme B; Le-Louët H
    Therapie; 2008; 63(5):385-92. PubMed ID: 19154708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective phenomena in drug trials.
    Gagnon MA
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):155-60. PubMed ID: 323162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A drug experience registry.
    Resman BH; McLeod DC
    Am J Hosp Pharm; 1976 Oct; 33(10):1051-3. PubMed ID: 973632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring adverse reactions to drugs.
    Royall BW
    WHO Chron; 1973 Nov; 27(11):469-75. PubMed ID: 4756663
    [No Abstract]   [Full Text] [Related]  

  • 18. The BrainIT group: concept and core dataset definition.
    Piper I; Citerio G; Chambers I; Contant C; Enblad P; Fiddes H; Howells T; Kiening K; Nilsson P; Yau YH;
    Acta Neurochir (Wien); 2003 Aug; 145(8):615-28; discussion 628-9. PubMed ID: 14520540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in elderly patients: alternative approaches to postmarket surveillance.
    Noah BA; Brushwood DB
    J Health Law; 2000; 33(3):383-454. PubMed ID: 11184355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.